Clinart has a strong position as an innovative, leading regional contract research organization offering a full-service end-to-end solution and access in the MENA region.
Clinart will support Clinerion by linking sites and hospitals to the global network on Clinerion’s Patient Network Explorer (PNEx) platform. This will help hospitals in the region be more visible and accessible for global trial sponsors and attract more studies to the region. Clinart will also offer services derived from PNEx for the running of local real-world evidence studies and academic research
The partnership supports Clinart’s vision to support patients and healthcare providers by making the region more visible to trial sponsors, attracting more international studies to the region, enabling capable local organizations to run real-world evidence projects, and facilitating local academic research across the region.
The collaboration will initially focus on the Gulf countries of the United Arab Emirates and Saudi Arabia. This will expand later to other countries in the region
“We are very excited about the opportunity to partner with Clinerion in the MENA region,” says Alaa Assem, President & CEO of Clinart. “We believe that the region can benefit from this partnership through the improvement of visibility of the region on a global level. By providing better access to Real World Evidence data and analytics from the region, we can generate a better understanding of disease prevalence and treatment patterns in geographies which are currently underrepresented. We are strongly positioned to support Clinerion with this initiative and also to support the sites with establishing the required infrastructure and resources needed to successfully deliver.”
“Clinerion is thrilled to have a partner who can support us in our efforts to improve patient outcomes in the MENA region,” says Ian Rentsch, CEO of Clinerion. “Clinart has an excellent reputation and a network capable of making things happen.”
Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion's Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.
Clinerion website: www.clinerion.com
Clinerion’s Patient Network Explorer: www.clinerion.com/index/OverviewOurSolutions/ClinerionPatientNetworkExplorer
About Clinart FZ LLC
Clinart MENA is a leading regional and innovative contract research organization, offering a full service End-to-End Solution for Phase I to IV / NIS /RWE studies in the Middle East and North Africa region. Clinart offers direct access to MENA countries and other African countries, in line with global standards and local cultures and regulations. Our international experience, as well as our proven track record of successful trials since 2001 assures our clients that Clinart MENA is their reliable partner for the MENA region. Clinart MENA HQ located in the Dubai Healthcare City, UAE, offering direct coverage to the Gulf region. In addition, our local offices in Saudi Arabia, Kuwait, Lebanon and Egypt and home-based CRAs offering extensive direct coverage across the region, ensuring that minor cultural differences across the region are well managed by our local teams. Our teams have extensive experience and strong network with all key research institutions and hospitals across the region.